Medidata01.12.22
Medidata, a Dassault Systèmes company, has named Rama Kondru and Sastry Chilukuri as co-CEOs. Both are Medidata veterans, with Chilukuri as the founding president of Medidata Acorn AI and Kondru as executive vice president and chief technology officer. Collaborating as CEOs will be nothing new for these industry leaders, having also partnered in roles prior to joining Medidata.
“The life sciences industry is undergoing a sea change spurred by biological and technological innovation. We at Medidata are committed to being a trusted partner who helps customers deploy cutting-edge technology, data and AI to solve the impossible for patients,” Chilukuri said.
Before joining Medidata, Chilukuri was a partner at McKinsey & Company, where he worked for 12 years advising bio-pharma, medical device, technology, PE and public sector clients around the world. Prior to that, he worked for GE Healthcare in software engineering, product development, and operations.
Kondru joined Medidata from Janssen Americas, a Johnson and Johnson company, where he was senior vice president and chief innovation officer (CIO) for Janssen Pharmaceuticals - Americas. Before that, he was CIO overseeing R&D and Innovation in the J&J Medical Devices group, and led a global data sciences team at J&J.
Kondru commented: "We are excited to build the next chapter of Medidata around three critical pillars: a unified platform covering the entire life cycle of drug development; 'maximizing analytics everywhere' to drive insights and efficiency and re-imagining the end-user experience for patients, sites, investigators, and researchers.”
Tarek Sherif and Glen de Vries, Medidata co-founders, will serve as chair and vice-chair of Dassault Systèmes Life Sciences & Healthcare, respectively. Their mission is to make Dassault Systèmes the leading platform for discovery, development, delivery, and the future state of healthcare around the world.
Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization. Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. Medidata is headquartered in New York City and has offices around the world.
Dassault Systèmes, the 3DEXPERIENCE Company, is a catalyst for human progress. The firm provides business and people with collaborative 3D virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with its 3DEXPERIENCE platform and applications, customers push the boundaries of innovation, learning and production. Dassault Systèmes brings value to more than 290,000 customers of all sizes, in all industries, in more than 140 countries.
“The life sciences industry is undergoing a sea change spurred by biological and technological innovation. We at Medidata are committed to being a trusted partner who helps customers deploy cutting-edge technology, data and AI to solve the impossible for patients,” Chilukuri said.
Before joining Medidata, Chilukuri was a partner at McKinsey & Company, where he worked for 12 years advising bio-pharma, medical device, technology, PE and public sector clients around the world. Prior to that, he worked for GE Healthcare in software engineering, product development, and operations.
Kondru joined Medidata from Janssen Americas, a Johnson and Johnson company, where he was senior vice president and chief innovation officer (CIO) for Janssen Pharmaceuticals - Americas. Before that, he was CIO overseeing R&D and Innovation in the J&J Medical Devices group, and led a global data sciences team at J&J.
Kondru commented: "We are excited to build the next chapter of Medidata around three critical pillars: a unified platform covering the entire life cycle of drug development; 'maximizing analytics everywhere' to drive insights and efficiency and re-imagining the end-user experience for patients, sites, investigators, and researchers.”
Tarek Sherif and Glen de Vries, Medidata co-founders, will serve as chair and vice-chair of Dassault Systèmes Life Sciences & Healthcare, respectively. Their mission is to make Dassault Systèmes the leading platform for discovery, development, delivery, and the future state of healthcare around the world.
Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization. Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. Medidata is headquartered in New York City and has offices around the world.
Dassault Systèmes, the 3DEXPERIENCE Company, is a catalyst for human progress. The firm provides business and people with collaborative 3D virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with its 3DEXPERIENCE platform and applications, customers push the boundaries of innovation, learning and production. Dassault Systèmes brings value to more than 290,000 customers of all sizes, in all industries, in more than 140 countries.